The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): An analysis of 649 cases

Lung Cancer

Volumn 76, Issue 3, 2012, Pages 344-349

  Lin, Michael ^a,b   Ambati, Chaitanya ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

FDG; Lung cancer; NSCLC; PET; PET CT; Positron Emission Tomography; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER STAGING; COLORECTAL POLYP; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; INCIDENTAL FINDING; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRECANCER; PRIORITY JOURNAL; SECOND CANCER; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;

EID: 84860520036     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.11.024     Document Type: Article

References (19)

1. Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., et al. Staging of non-small-cell lung cancer with integrated Positron-Emission Tomography and Computed Tomography. N Engl J Med 2003, 348:2500-2507.
2. Lin M., Shon I.H., Lin P. Positron emission tomography: current status and future challenges. Int Med J 2010, 40:19-29.
3. Søgaard R., Fischer B., Mortensen J., Højgaard L., Lassen U. Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial. Eur J Nucl Med Mol Imaging 2011, 38:802-809.
4. Metser U., Even-Sapir E. Increased 18F-Fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body Positron Emission Tomography/Computed Tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med 2007, 37:206-222.
5. Lin P., Koh E.S., Lin M., Vinod S.K., Ho-Shon I., Yap J., et al. Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer. Radiother Oncol 2011, 101:284-290.
6. Liu F.Y., Liao C.T., Yen T.C. Synchronous malignancies in patients with squamous cell carcinomas of the oral cavity. Eur J Nucl Med Mol Imaging 2011, 38:1020-1028.
7. Choi J.Y., Lee K.S., Kwon O.J., Shim Y.M., Baek C.-H., Park K., et al. Improved detection of second primary cancer using Integrated [18F] Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography for initial tumor staging. J Clin Oncol 2005, 23:7654-7659.
8. Ishimori T., Patel P.V., Wahl R.L. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005, 46:752-757.
9. Even-Sapir E., Lerman H., Gutman M., Lievshitz G., Zuriel L., Polliack A., et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging 2006, 33:541-552.
10. Strobel K., Haerle S., Stoeckli S., Schrank M., Soyka J., Veit-Haibach P., et al. Head and neck squamous cell carcinoma (HNSCC) - detection of synchronous primaries with 18F-FDG-PET/CT. Eur J Nucl Med Mol Imaging 2009, 36:919-927.
11. van Westreenen H.L., Westerterp M., Jager P.L., van Dullemen H.M., Sloof G.W., Comans E.F.I., et al. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med 2005, 46:1321-1325.
12. De Wever W., Vankan Y., Stroobants S., Verschakelen J. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J 2007, 29:995-1002.
13. Lardinois D., Weder W., Roudas M., von Schulthess G.K., Tutic M., Moch H., et al. Etiology of solitary extrapulmonary Positron Emission Tomography and Computed Tomography findings in patients with lung cancer. J Clin Oncol 2005, 23:6846-6853.
14. Lin M., Wong C., Lin P., Shon I.H., Cuganesan R., Som S. The prevalence and clinical significance of 18F-2-fluoro-2-deoxy-d-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Hematol Oncol 2011, 29:67-74.
15. Lin M., Koo J.H., Abi-Hanna D. Management of patients following detection of unsuspected colon lesions by PET imaging. Clin Gastroenterol Hepatol 2011, 9:1025-1032.
16. Kamel E.M., Goerres G.W., Burger C., von Schulthess G.K., Steinert H.C. Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion-Report of six cases. Radiology 2002, 224:153-156.
17. Ahnen D.J. The American College of Gastroenterology Emily Couric Lecture - the adenoma-carcinoma sequence revisited: has the era of genetic tailoring finally arrived?. Am J Gastroenterol 2011, 106:190-198.
18. Ackroyd F.W., Hedberg S.E. Colonic polyps. Annu Rev Med 1985, 36:619-625.
19. Wong C., Lin M., Chicco A., Benson R. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy 2011, 52:899-904.